Number of shares outstanding for Hologic (HOLX)

Number of shares outstanding in March 2024 : 224,405,000

According to Hologic's latest financial reports and stock price the company's current number of shares outstanding is 224,405,000. At the end of 2024 the company had 235,890,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Hologic from 2008 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.23 B	-1.15%
2023	0.23 B	-3.51%
2022	0.24 B	-2.44%
2021	0.25 B	-1.97%
2020	0.25 B	-3.47%
2019	0.26 B	-1%
2018	0.27 B	-2.26%
2017	0.27 B	-0.65%
2016	0.27 B	-1.52%
2015	0.28 B	1.54%
2014	0.27 B	2.19%
2013	0.27 B	2.39%
2012	0.26 B	1.38%
2011	0.26 B	1.19%
2010	0.25 B	0.62%
2009	0.25 B	0.71%
2008	0.25 B

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Johnson & Johnson JNJ	2,409,600,000	973.77%	🇺🇸 USA
Abbott Laboratories ABT	1,730,383,296	671.10%	🇺🇸 USA
Thermo Fisher Scientific TMO	370,000,000	64.88%	🇺🇸 USA
Becton Dickinson BDX	274,788,000	22.45%	🇺🇸 USA
Boston Scientific BSX	1,448,700,000	545.57%	🇺🇸 USA
General Electric GE	1,035,000,000	361.22%	🇺🇸 USA
Quest Diagnostics DGX	110,000,000	-50.98%	🇺🇸 USA
Philips PHG	955,573,000	325.83%	🇳🇱 Netherlands

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions